Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+0.68%
Mudança mensal
0.00%
Mudança em 6 meses
-16.07%
Mudança anual
-16.07%
Fechamento anterior
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volume
101
Mercados
Ações
Cuidados de saúde
ZVRA
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Notícias
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, président de Zevra Therapeutics, vend des actions pour 125k $
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Le directeur médical de Zevra Therapeutics vend des actions pour 40.000€
Joshua Schafer, CCO de Zevra, vend des actions ZVRA pour 29.800€
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
Le PDG de Zevra Therapeutics, McFarlane, vend des actions pour 853.425€
Zevra Therapeutics CEO McFarlane sells $853k in shares
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)